biztrac. BETA
COMPANY REGISTER PROFILE
936564046 ORG. NO. 2025 ACCOUNTS 7 SECTIONS
Active UPDATED 03.10.2026
Computer programming activities

MEDINNOVA AS

Org. no. 936564046 Limited company (AS) Oslo Incorporated 2025 Active
Revenue 2025 NOK 0
Operating profit NOK −10,000
Equity NOK 20,000
Incorporated 2025
Share capital NOK 30,000

Signals

1 flags
  • Driftsunderskudd 2025 Siste driftsresultat er negativt (−10k kr).

MEDINNOVA AS is registered as a limited company in Oslo, Oslo with organisation number 936564046. The business is classified under computer programming activities (NACE 62.100). The company was incorporated in 2025. Registered share capital is NOK 30,000, divided into 100 shares. The company's stated purpose is: “Lage og selge digitale løsninger til helsepersonell.”. The most recent filed accounts, for the 2025 financial year, show NOK 0 in revenue and NOK −10,000 in operating profit.

Key figures · 2025

Revenue
NOK 0
Operating profit
NOK −10,000
Equity
NOK 20,000
Est. value
NOK 37,000

Financial health · 2025

Liquidity
–
Not available
Current assets ÷ current liabilities
Profitability
–
Not available
Return on total assets
Solidity
100.0%
Weak
Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns MEDINNOVA AS?

MEDINNOVA AS
NOK 0 rev. · NOK −10,000 profit

MEDINNOVA AS has 2 registered shareholders:

All shareholders and roles →

Frequently asked questions about MEDINNOVA AS

Who owns MEDINNOVA AS?

HI4 SOLUTIONS AS is the largest registered owner, with 90.0%.

What is the revenue of MEDINNOVA AS?

MEDINNOVA AS had revenue of NOK 0 in 2025.

Who is the general manager of MEDINNOVA AS?

Nadeem Asjid is registered as general manager of MEDINNOVA AS.

Where is MEDINNOVA AS based?

MEDINNOVA AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.